Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AI

Sep 05, 2024•almost 2 years ago

Contract Type

partnership

New YorkBiotechnologyHealth CareArtificial Intelligence

Description

Genetic Leap and Eli Lilly and Company have entered a research collaboration to develop genetic medicine therapeutics using Genetic Leap's RNA-targeted AI platform. The collaboration aims to generate oligonucleotide drugs against targets selected by Lilly in high priority therapeutic areas, leveraging the potential of RNA in addressing critical diseases that traditional drugs have not effectively targeted.

Company Information

Company

Genetic Leap

Location

New York, New York, United States

About

Genetic Leap is innovating at the cutting edge of AI and RNA genetic medicine to redefine drug development and more quickly address the health needs of millions of people.

Predictive Intelligence
Strategic

ML-powered predictions for Genetic Leap's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.